The Royal Pharmaceutical Society is pleased to announce that the new Director for England will be Robbie Turner. This important post supports the work of the English Board, and directs its extensive programme to develop the profession in England and support and engage members across the nation.
Robbie is currently Chief Executive of Community Pharmacy West Yorkshire, an organisation that represents over 560 local community pharmacies. Robbie is also a Fellow of the RSA, Chair of Governors at Ninelands Primary School and a Trustee of Pharmacist Support, an independent charity working for pharmacists and their families. Robbie has previously worked in management positions for Cohen’s Chemists and the Assura Group.
Helen Gordon, RPS Chief Executive said:
“I’m delighted to be welcoming Robbie to the Society and my team, at such an important time of challenge and opportunity for pharmacists and pharmacy in England. Robbie brings with him a tremendous range of experience and skills rooted in a deep knowledge of pharmacy that will really help the RPS in England serve members well and contribute powerfully to national health policy.”
Robbie Turner said:
“I am absolutely delighted to be joining the Royal Pharmaceutical Society and am looking forward to working with the English Pharmacy Board to support and further develop the role of pharmacists. I have always been impressed by the work the RPS has achieved in advancing the profession of pharmacy and am very excited to be able to help contribute to building on this.”
Sandra Gidley, chair of the RPS English Pharmacy board said:
“Robbie is an exceptional local leader, who has already impressed me and my colleagues with his passion and commitment for the profession. Robbie will be joining a talented team of pharmacist board members and staff, who have delivered impressive results over recent years. Working with the English board to develop a long term, strategic response to reforms in community and hospital pharmacy, as well as education and wider NHS England reforms, will be a key focus. I look forward to working with Robbie to deliver successful results for our members, their patients and the wider public.”
Robbie will take up his post on 16th January 2017.